Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children

Acta Tropica

Volumn 101, Issue 1, 2007, Pages 31-39

  Eperon, Gilles ^a,b   Schmid, Caecilia ^c   Loutan, Louis ^b   Chappuis, François ^a,b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Adverse events; African trypanosomiasis; Children; Melarsoprol; Pentamidine; Sleeping sickness

Indexed keywords

EFLORNITHINE; FOLIC ACID; IRON; MEBENDAZOLE; MELARSOPROL; MULTIVITAMIN; PENTAMIDINE; PREDNISOLONE; PYRIMETHAMINE SULFADIAZINE;

CHILD HEALTH; DEMOGRAPHY; DISEASE TREATMENT; SYMPTOM; TOXICITY; TRYPANOSOMIASIS; TSETSE FLY;

ADOLESCENT; AFRICAN TRYPANOSOMIASIS; ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CONSCIOUSNESS; CONTINUOUS INFUSION; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEVER; HEADACHE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INJECTION SITE ABSCESS; INJECTION SITE NECROSIS; JAUNDICE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PANCREATITIS; POLYNEUROPATHY; PRESCHOOL CHILD; PSYCHOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SKIN NECROSIS; SPEECH DISORDER; SUDAN; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREMOR; TRYPANOSOMA GAMBIENSE; VESICULAR RASH; VOMITING; WALKING DIFFICULTY;

ADOLESCENT; AGE FACTORS; ANIMALS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MELARSOPROL; PENTAMIDINE; RETROSPECTIVE STUDIES; SUDAN; TREATMENT OUTCOME; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

AFRICA; AL-ISTIWAI; EAST AFRICA; KAJO KEJI; SUB-SAHARAN AFRICA; SUDAN;

TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 33846848122     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.12.002     Document Type: Article

References (33)

1. Abel P.M., Kiala G., Loa V., Behrend M., Musolf J., Fleischmann H., Theophile J., Krishna S., and Stich A. Retaking sleeping sickness control in Angola. Trop. Med. Int. Health 9 (2004) 141-148
2. Ammon J., and Richterich R. The determination of normal values of glucose, protein and cell concentrations in the cerebrospinal fluid of children. Schweiz. Med. Wochenschr. 100 (1970) 1317-1320
3. Balasegaram M., Harris S., Checchi F., Ghorashian S., Hamel C., and Karunakara U. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull. WHO 84 (2006) 783-791
4. Blum J., Schmid C., and Burri C. Clinical aspects of 2541 patients with second-stage human African trypanosomiasis. Acta Trop. 97 (2006) 55-64
5. Boa Y.F., Traore M.A., Doua F., Kouassi-Traore M.T., Kouassi B.E., and Giordano C. The different present-day clinical picture of human African trypanosomiasis caused by T. b. gambiense. Analysis of 300 cases from a focus in Daloa, Ivory Coast. Bull. Soc. Pathol. Exot. 81 (1988) 427-444
6. Chappuis F., Pittet A., Bovier P.A., Adams K., Godineau V., Hwang S.Y., Magnus E., and Büscher P. Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan. Trop. Med. Int. Health 7 (2002) 942-948
7. Chappuis F., Udayraj N., Stietenroth K., Meussen A., and Bovier P.A. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clin. Infect. Dis. 41 (2005) 748-751
8. Cramet R. Sleeping sickness in children and its long-term after-effects. Apropos 110 personal observations at Fontem Hospital (Cameroon). Med. Trop. 42 (1982) 27-31
9. De Raadt P. Congenital trypanosomiasis and leishmaniasis. Arch. Française Ped. 42 (1985) 925-927
10. Debroise A., Debroise-Ballereau C., Satge P., and Rey M. African trypanosomiasis in young children. Arch. Française Ped. 25 (1968) 703-720
11. Ginoux P.Y., Frezil J.L., and Alary J.C. Symptoms of human trypanosomiasis at the first diagnostic phase in the People Republic of Congo (author's transl). Med. Trop. 42 (1982) 281-287
12. Haller L., Adams H., Merouze F., and Dago A. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy. Am. J. Trop. Med. Hyg. 35 (1986) 94-99
13. Hughes W.T., Price R.A., Kim H.K., Coburn T.P., Grigsby D., and Feldman S. Pneumocystis carinii pneumonitis in children with malignancies. J. Ped. 82 (1973) 404-415
14. Hughes W.T., Feldman S., Chaudhary S.C., Ossi M.J., Cox F., and Sanyal S.K. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Ped. 92 (1978) 285-291
15. Kazumba M., Kazadi K., and Mulumba M.P. Characteristics of trypanosomiasis in children. Apropos of 19 case reports at the CNPP (Neuro-Psycho-Pathology Center), University Hospitals of Kinshasa, Zaire. Ann. Soc. Belge Med. Trop. 73 (1993) 253-259
16. Koko J., Dufillot D., Gahouma D., Amblard J., and Kani F. Human African trypanosomiasis in children. A pediatrics service experience in Libreville, Gabon. Bull. Soc. Pathol. Exot. 90 (1997) 14-18
17. Le Bras J., Sina G., Triolo N., and Trova P. Symptomatologie générale de la trypanosomiase humaine africaine de l'enfant. A propos de 93 cas. Med. Trop. 37 (1977) 51-61
18. Lutumba P., Robays J., Miaka mia Bilenge C., Mesu V.K., Molisho D., Declercq J., Van der Veken W., Meheus F., Jannin J., and Boelaert M. Trypanosomiasis control, Democratic Republic of Congo 1993-2003. Emerg. Infect. Dis. 11 (2005) 1382-1388
19. Magnus E., Vervoort T., and Van Meirvenne N. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belge Med. Trop. 58 (1978) 169-176
20. Moore A., and Richer M. Re-emergence of epidemic sleeping sickness in southern Sudan. Trop. Med. Int. Health 6 (2001) 342-347
21. Ngandu-Kabeya G. Study of the symptomatology of African trypanosomiasis in children (apropos of 24 cases). Ann. Soc. Belge Med. Trop. 56 (1976) 85-93
22. Pepin J., and Khonde N. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramine. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 183-186
23. Pepin J., and Meda H.A. The epidemiology and control of human African trypanosomiasis. Adv. Parasitol. 49 (2001) 71-132
24. Pepin J., and Milord F. The treatment of human African trypanosomiasis. Adv. Parasitol. 33 (1994) 1-47
25. Pepin J., Milord F., Khonde A.N., Niyonsenga T., Loko L., Mpia B., and De Wals P. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 92-97
26. Portnoy J.M., and Olson L.C. Normal cerebrospinal fluid values in children: another look. Pediatrics 75 (1985) 484-487
27. Sands M., Kron M.A., and Brown R.B. Pentamidine: a review. Rev. Infect. Dis. 7 (1985) 625-634
28. Schmid C., Richer M., Bilenge C.M., Josenando T., Chappuis F., Manthelot C.R., Nangouma A., Doua F., Asumu P.N., Simarro P.P., and Burri C. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (Impamel II). J. Infect. Dis. 191 (2005) 1922-1931
29. Snow W.F., Declercq J., and van Nieuwenhove S. Watering sites in Glossina fuscipes habitat as the major foci for the transmission of gambiense sleeping sickness in an endemic area of southern Sudan. Ann. Soc. Belge Med. Trop. 71 (1991) 27-38
30. Triolo N., Trova P., Fusco C., and Le Bras J. Report on l7 years of studies of human African trypanosomiasis caused by T. gambiense in children 0-6 years of age. Med. Trop. 45 (1985) 251-257
31. Walzer P.D., Perl D.P., Krogstad D.J., Rawson P.G., and Schultz M.G. Pneumocystis carinii pneumonia in the United States. Ann. Intern. Med. 80 (1974) 83
32. Wenzel D., and Felgenhauer K. The development of the blood-CSF barrier after birth. Neuropädiatrie 7 (1976) 175-181
33. WHO. Human African trypanosomiasis (sleeping sickness): epidemiological update. Weekly Epidemiol. Rec. (2006) 71-80